Clinical Trials · NCT07701005
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Goztepe Prof Dr Suleyman Yalcın City Hospital
- Enrollment
- 154
- Start date
- Jan 2024
- Locations
- 1 site, Turkey (Türkiye)
- Primary endpoint
- Change in Fibrosis-4 Index (FIB-4)